ACUTE-, LATE- AND RESOLUTION PHASE OF THE ASTHMATIC RESPONSE IN THE SMALL AIR
小空气中哮喘反应的急性期、晚期期和消退期
基本信息
- 批准号:7718007
- 负责人:
- 金额:$ 0.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-12-01 至 2008-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdrenal Cortex HormonesAirAlveolarAnti-Inflammatory AgentsAnti-inflammatoryAntigensAsthmaBreathingComputer Retrieval of Information on Scientific Projects DatabaseDistalExhalationFelis catusFrequenciesFundingFutureGrantImmunologic MarkersIndividualInflammatoryInspiratory CapacityInstitutionInvasiveLifeLungLung InflammationMeasuresNitric OxidePhasePhysiologicalPulmonary Function Test/Forced Expiratory Volume 1RateResearchResearch PersonnelResidual volumeResistanceResolutionResourcesSourceSteroidsSymptomsTechniquesTimeUnited States National Institutes of Healthairway inflammationcomputerizedlung imagingnovelpredictive modelingrespiratoryresponse
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
SPECIFIC AIMS:
Primary Objective: The overall objective of this study is to characterize small airways function during the resolution of an acute exacerbation by novel radiographic techniques and physiologic measures and correlate those findings with the resolution of small airways inflammatory markers. The asthma exacerbation (AE) will be experimentally induced by a naturalistic challenge with cat antigen (Fel d I), which is known to penetrate the distal airways. Mild to moderate, steroid na¿ve asthmatic subjects will be exposed in a cat room, containing a known concentration of Fel d I per m3 of air from resident, live cats, for a sufficient period of time to provoke a 20% decline in FEV1. Distal airways response will be assessed at baseline and at various times following a cat room challenge using the following measures: 1) novel radiographic techniques (quantitative analysis of high-resolution computerized tomographic [HRCT] images of the lung acquired at residual volume) 2) physiologic studies (inspiratory capacity [IC], isovolume mid flow rate [FEF25-75%, iso], and impulse oscillation [IOS] respiratory resistance at different frequencies and IOS reactance), 3) exhaled nitric oxide (FENO), including the computed alveolar component of FENO, and 4) bioimmunologic markers (immunologic markers of distal lung inflammation obtained via bronchoscopic distal lung brushings). Once the time course to resolution of the radiographic, physiologic and inflammatory changes in the small airways is ascertained, the following secondary objectives will be addressed in future studies.
Secondary Objectives: a) establish if unresolved small airways inflammation, after an initial cat room challenge, in the setting of normalized FEV1 and symptoms, predisposes to a more pronounced exacerbation after a secondary cat room challenge; b) evaluate alterations in mechanisms of small airways inflammation in individuals treated or not treated with anti-inflammatory therapy targeted to the small airways, i.e., with an extra-fine vs. a coarse inhaled corticosteroid (ICS); and c) to use the non-invasive measures of small airways abnormalities employed in this study to develop a predictive model for resolution of acute asthma exacerbations which more closely parallels the inflammatory resolution of natural acute asthma exacerbations.
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
具体目标:
主要目的:本研究的总体目的是通过新的放射学技术和生理学测量来表征急性加重消退期间的小气道功能,并将这些发现与小气道炎症标志物的消退相关联。哮喘急性发作(AE)将通过猫抗原(Fel d I)的自然激发实验诱导,已知猫抗原可穿透远端气道。轻度至中度、类固醇初治哮喘受试者将在猫房中暴露足够长的时间,以引起FEV 1下降20%,猫房中含有已知浓度的Fel d I/m3空气(来自居住的活猫)。将在基线和猫房激发后的不同时间使用以下指标评估远端气道反应:1)新的放射学技术(定量分析在残余体积下获得的肺部高分辨率计算机断层扫描[HRCT]图像)2)生理学研究(吸气量[IC]、等容中流速[FEF 25 - 75%,iso]和不同频率下的脉冲振荡[IOS]呼吸阻力和IOS电抗),3)呼出一氧化氮(FENO),包括FENO的计算肺泡成分,和4)生物免疫学标记物(通过支气管镜远端肺刷获得的远端肺炎症的免疫学标记物)。一旦确定了小气道放射学、生理学和炎症变化消退的时间进程,将在未来的研究中解决以下次要目标。
次要目的:a)在标准化的FEV 1和症状的情况下,在初始猫房攻击后,确定未解决的小气道炎症是否倾向于在二次猫房攻击后更明显的恶化; B)评估用靶向小气道的抗炎疗法治疗或未治疗的个体中小气道炎症机制的改变,即,使用超细吸入皮质类固醇(ICS)与粗吸入皮质类固醇(ICS);以及c)使用本研究中采用的小气道异常的非侵入性测量来开发用于缓解急性哮喘恶化的预测模型,其更接近地平行于自然急性哮喘恶化的炎症缓解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DONALD P TASHKIN其他文献
COMPUTER-ASSISTED QUANTITATIVE IMAGE ANALYSIS FOR IDENTIFICATION OF PULMONARY FIBROSIS AND EMPHYSEMA: PATHWAY TO CHARACTERIZING CPFE
- DOI:
10.1016/j.chest.2023.07.2613 - 发表时间:
2023-10-01 - 期刊:
- 影响因子:
- 作者:
DANIEL HOESTEREY;GRACE HYUN KIM;JIHEY LEE;ANDREA OH;LILA POURZAND;JONATHAN G GOLDIN;ERIC A HOFFMAN;JENNIFER WANG;MEILAN K HAN;CHRISTOPHER B COOPER;DONALD P TASHKIN;IGOR BARJAKTAREVIC;FEREIDOUN ABTIN - 通讯作者:
FEREIDOUN ABTIN
DONALD P TASHKIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DONALD P TASHKIN', 18)}}的其他基金
Distal Lung Inflammation Effect on Asthma Exacerbations
远端肺部炎症对哮喘加重的影响
- 批准号:
7266947 - 财政年份:2005
- 资助金额:
$ 0.11万 - 项目类别:
Distal Lung Inflammation Effect on Asthma Exacerbations
远端肺部炎症对哮喘加重的影响
- 批准号:
7121950 - 财政年份:2005
- 资助金额:
$ 0.11万 - 项目类别:
Distal Lung Inflammation Effect on Asthma Exacerbations
远端肺部炎症对哮喘加重的影响
- 批准号:
6913825 - 财政年份:2005
- 资助金额:
$ 0.11万 - 项目类别:
Distal Lung Inflammation Effect on Asthma Exacerbations
远端肺部炎症对哮喘加重的影响
- 批准号:
7473920 - 财政年份:2005
- 资助金额:
$ 0.11万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 0.11万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 0.11万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 0.11万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 0.11万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 0.11万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 0.11万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 0.11万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 0.11万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 0.11万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 0.11万 - 项目类别:
Research Grant














{{item.name}}会员




